Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Nīmes
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 138 people enrolled
- Started
- 10 Sept 2024
- Ended
- 11 Feb 2025
- Type of study
- Observational
- Record updated
- 18 February 2025
- Why it stopped
- difficulty of inclusion, PI decision
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Currently in a relationship or has been in one in the last 12 months, regardless of the length of the relationship
- Willing to complete the anonymous WAST self-questionnaire
- able to read and understand French
- Outpatient consultant at Nîmes University Hospital in one of the following departments:; Biological hematology consultation; Clinical hematology consultation; Vascular medicine consultation
Who cannot take part
- Individuals under court protection, guardianship or curatorship
- Individuals unable to read and understand French
- Individuals who have already completed the WAST questionnaire during the study period
- Individuals unable to get away from their partner during the consultation to complete the questionnaire in isolation
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world.
Read full original descriptionShow less
The Women Abuse Screening Tool (WAST) self-questionnaire is a screening tool validated in French.
Our preliminary data describing the association between intimate violence against women and the first attack of unexplained venous thromboembolic disease, show a significant frequency of positive responses to the WAST among women attending a biological hematology consultation at the CHU de Nîmes, for reasons of hemostasis disorders (8% out of the first 200 cases).
The study authors wish to establish the prevalence of this situation among patients presenting to the CHU de Nîmes for hematological exploration and management. They hypothesize that the prevalence of violence against individuals seen in Hematology consultations is higher among individuals with hemostasis pathologies (hemorrhagic and thrombotic pathologies) than those with cellular pathologies, and higher among women than men.
The group in the trial
- Patients presenting at a biological hematology consultation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 February 2025